Literature DB >> 1312736

Adenocarcinoma of the pancreatic ducts: comparative evaluation with CT and MR imaging at 1.5 T.

A D Vellet1, W Romano, D B Bach, R B Passi, D H Taves, P L Munk.   

Abstract

A prospective comparison of computed tomography (CT) and magnetic resonance (MR) imaging at 1.5 T was performed in 50 patients with the suspected diagnosis of pancreatic carcinoma. CT scans were obtained before and after administration of contrast material in 41 of 50 patients (82%); 34 of 41 postcontrast scans (83%) were obtained with dynamic CT. MR images were interpreted without knowledge of the results of CT, ultrasound, cholangiography, or endoscopic retrograde cholangiopancreatography in 48 patients (96%). Surgical correlation of findings at CT and MR imaging was performed in 24 patients (48%) at laparotomy and in two patients (4%) at autopsy. On T1-weighted MR images, relatively diminished signal intensity of tumor compared with that of the adjacent pancreas was a consistent finding. MR imaging proved superior to CT in identification of pancreatic carcinoma (particularly in smaller intrapancreatic tumors), peripancreatic extension, vascular and portal vein invasion, and duodenal invasion. These results suggest that MR imaging of the pancreas is superior in many instances to CT in preoperative evaluation of pancreatic carcinoma.

Entities:  

Mesh:

Year:  1992        PMID: 1312736     DOI: 10.1148/radiology.183.1.1312736

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

Review 1.  Magnetic resonance imaging of pancreatic adenocarcinoma.

Authors:  L M Fayad; D G Mitchell
Journal:  Int J Gastrointest Cancer       Date:  2001

Review 2.  Diffusion-weighted imaging of pancreatic cancer.

Authors:  Riccardo De Robertis; Paolo Tinazzi Martini; Emanuele Demozzi; Flavia Dal Corso; Claudio Bassi; Paolo Pederzoli; Mirko D'Onofrio
Journal:  World J Radiol       Date:  2015-10-28

3.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.

Authors: 
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

4.  Controversial issues in the management of pancreatic cancer: Part one. A debate held at St Mary's Hospital, London on 18 November 1993.

Authors:  G Glazer; C Coulter; M E Crofton; W M Gedroyc; C D Johnson; C N Mallinson; R C Russell; M L Steer; J A Summerfield; R C Williamson
Journal:  Ann R Coll Surg Engl       Date:  1995-03       Impact factor: 1.891

5.  High-resolution MRI of pancreatic masses with a new circularly polarized body phased-array coil.

Authors:  K Engelhard; H P Hollenbach
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

Review 6.  Diagnostic accuracy of EUS and CT of vascular invasion in pancreatic cancer: a systematic review.

Authors:  RenBao Yang; ManPeng Lu; XiaoXing Qian; Jiong Chen; Liang Li; JiaWen Wang; YouQian Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2014-06-11       Impact factor: 4.553

7.  Positron emission tomography (PET) has limited utility in the staging of pancreatic adenocarcinoma.

Authors:  Peter Einersen; Irene Epelboym; Megan D Winner; David Leung; John A Chabot; John D Allendorf
Journal:  J Gastrointest Surg       Date:  2014-06-14       Impact factor: 3.452

8.  18F-FDG PET/MRI fusion in characterizing pancreatic tumors: comparison to PET/CT.

Authors:  Mitsuaki Tatsumi; Kayako Isohashi; Hiromitsu Onishi; Masatoshi Hori; Tonsok Kim; Ichiro Higuchi; Atsuo Inoue; Eku Shimosegawa; Yutaka Takeda; Jun Hatazawa
Journal:  Int J Clin Oncol       Date:  2011-02-24       Impact factor: 3.402

9.  Intrapancreatic accessory spleen. A rare cause of a pancreatic mass.

Authors:  J M Läuffer; H U Baer; C A Maurer; M Wagner; A Zimmermann; M W Büchler
Journal:  Int J Pancreatol       Date:  1999-02

Review 10.  Carcinoma of the head of the pancreas versus chronic pancreatitis: diagnostic dilemma with significant consequences.

Authors:  Bryce Taylor
Journal:  World J Surg       Date:  2003-10-13       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.